Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066069

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 6, 2015
Accepted (ET)
Aug 14, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 6, 2015J68$0.00A68D
Common StockAug 6, 2015J324$0.00A392D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$7.62holding————Mar 19, 2022Common Stock15,00015,000D
Stock Option (Right to Buy)F4$6.79holding————Feb 3, 2023Common Stock15,00015,000D
Stock Option (Right to Buy)F5$13.10holding————Jan 7, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F6$23.51holding————Dec 31, 2024Common Stock15,00015,000D

Explanation of responses